The presentation of the RINGSIDE trial data in May marked an important moment for the desmoid tumor community. Join the DTRF and Dr. Rashmi Chugh, MD, of University of Michigan Health, for a timely discussion of the latest findings from the clinical study evaluating varegacestat, an investigational gamma secretase inhibitor (GSI) being studied for the treatment of desmoid tumors.

During this webinar, Dr. Chugh will break down the RINGSIDE trial results in clear, patient-friendly language, helping attendees understand what the data showed, how varegacestat works, and what these findings may mean for the future of desmoid tumor treatment. Whether you are living with a desmoid tumor, caring for a loved one, or advocating within the community, this session is designed to help you feel more informed and confident when discussing treatment options with your medical team.

We’ll reserve dedicated time for an in-depth Q&A, giving attendees the opportunity to ask questions and hear directly from one of the leading experts in desmoid tumor care and research.

Register today!

Please Note: 

This webinar is intended solely for educational and informational purposes. The information presented as a part of this webinar, and any other material published in relation to this webinar, are provided for general purposes only and not intended to replace medical advice.

The content of this webinar may not apply directly to specific circumstances and is not intended to be a substitute for professional medical advice, diagnosis, or treatment provided by your own medical provider or mental health provider. 

The DTRF does not endorse any treatments or studies.